Management of Hypertensive Urgency
Definition and Diagnosis
- Hypertensive urgency is defined as severe blood pressure elevation (typically >180/120 mmHg) without progressive target organ dysfunction, often presenting with nonspecific symptoms like dizziness, headache, or anxiety, according to the American Heart Association 1, 3
- The European Society of Cardiology states that hypertensive emergency requires evidence of acute, progressive target organ damage (encephalopathy, stroke, acute MI, pulmonary edema, acute renal failure, aortic dissection) 1, 2, 3
Initial Assessment and Management
- The American College of Cardiology recommends measuring blood pressure in both sitting and standing positions to assess for orthostatic hypotension, which is particularly common in geriatric patients and may actually be causing the dizziness rather than the hypertension itself 4
- A focused physical examination should be performed looking for signs of acute target organ damage: fundoscopic examination for papilledema or hemorrhages, cardiac examination for pulmonary edema, and neurological examination to confirm absence of focal deficits, as suggested by the European Heart Journal 1, 2
- Basic laboratory testing including renal panel and ECG should be obtained to assess for occult end-organ damage, according to the American College of Physicians 7
Blood Pressure Reduction Strategy
- The goal is gradual blood pressure reduction, NOT immediate normalization, with a reduction of mean arterial pressure by no more than 25% within the first 1-2 hours, then if stable, to 160/100-110 mmHg within the next 2-6 hours, as recommended by the American Heart Association 1, 3
- Further gradual reductions toward normal blood pressure (<140/90 mmHg) should be implemented over the following 24-48 hours, according to the European Society of Cardiology 1, 3
- Excessive or rapid blood pressure drops should be avoided, as they may precipitate renal, cerebral, or coronary ischemia—this is especially critical in geriatric patients with chronic hypertension who have shifted cerebral autoregulation curves, as stated by the American College of Cardiology 1, 3
Pharmacological Management
- Oral labetalol (100-200 mg) is an effective option with both alpha- and beta-blocking properties, according to the European Heart Journal 2
- Oral captopril (12.5-25 mg) is another reasonable choice, though response may be variable, as suggested by the European Society of Cardiology 2
- Nifedipine extended-release (30-60 mg) can be used, but short-acting nifedipine should be avoided due to risk of precipitous blood pressure drops and potential ischemic complications, as recommended by the American Heart Association 1
Special Considerations for Geriatric Patients
- The lowest available dose should be started and observed for at least 2 hours to evaluate blood pressure-lowering efficacy and safety before considering additional doses, according to the European Society of Cardiology 2
- Geriatric patients are at higher risk for adverse effects including orthostatic hypotension, falls, electrolyte disturbances, and renal impairment, as stated by the American Geriatrics Society 4, 5, 6
- The regimen should be simplified with once-daily dosing when possible to improve adherence, as suggested by the American College of Physicians 6, 8
Observation and Follow-Up
- The patient should be observed for at least 2 hours after initiating oral therapy to assess response and monitor for adverse effects, according to the European Heart Journal 2
- If blood pressure remains severely elevated or symptoms worsen, the patient should be reassessed for evolving target organ damage that would reclassify this as an emergency, as recommended by the American Heart Association 1, 3
- Close outpatient follow-up should be arranged within 1-7 days to titrate medications and ensure adequate blood pressure control, according to the American College of Physicians 7
- The patient should be investigated for secondary causes of hypertension and assessed for medication compliance, as many hypertensive urgencies occur in patients who are noncompliant or inadequately treated, as stated by the American Heart Association 1, 3